Peripheral arterial occlusive disease (PAOD) outcomes are rarely prespecified in randomised type 2 diabetes trials, limiting comparative inference across glucagon-like peptide-1 receptor agonists (GLP-1RAs).
To compare GLP-1RA regimens for PAOD risk in adults with type 2 diabetes.
We conducted a PRI...
R. Amani-Beni, B. Darouei, S. Maleki et al.· European Heart Journal· 0 citations
In this population-based cohort of adults with insulin-treated T2D and CCN, CGM initiation was associated with fewer hospitalizations, shorter hospital stays, and lower hospitalization costs, supporting the integration of diabetes technology into chronic care strategies for highly vulnerable populations.
Pablo Rodríguez de Vera Gómez, Á. M. Mesa Díaz, E. Mayoral-Sánchez et al.· Diabetes Technology & Therap...· 0 citations
Topics covered include selection criteria for management with diabetes technologies, CGM-derived glycaemic metrics and goals for adults with diabetes, insulin titration and administration guidelines, perioperative care, CGM alarm settings for hypoglycaemia and hyperglycaemia, clinical staff training and workflows, inte...
M. T. Olsen, E. Spanakis, H. Thabit et al.· Diabetologia· 0 citations
Topics covered include selection criteria for management with diabetes technologies, CGM-derived glycemic metrics and goals for adults with diabetes, insulin titration and administration guidelines, perioperative care, CGM alarm settings for hypoglycemia and hyperglycemia, clinical staff training and workflows, integra...
M. T. Olsen, E. Spanakis, H. Thabit et al.· Diabetes Care· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.